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Background: Ischemic heart disease and stroke are two severe types of cardiovascular disease (CVD), a major
contributor to the global burden of disease. The preventive framework currently includes promotion of both
adequate cardiorespiratory and muscular fitness. Although muscle fitness is established as an indicator of health, it is
currently unknown whether muscle strength is associated with later CVD independently of cardiorespiratory fitness.
Methods: We studied 38,588 Swedish men who in 1969 to 1970 (typically aged 18 years) completed compulsory
conscription. Using the mean standardized score of three isometric muscle strength tests performed at conscription
(hand grip, elbow flexion and knee extension), we categorized the subjects into three groups with the 25th to 75th
percentile defining the reference category. We followed the cohort until 2012 for diagnosed CVD events and mortality
via national health care registers and the national cause of death register. To estimate hazard ratios (HR) for CVD events
(coronary heart disease or stroke) and CVD mortality we used Cox proportional hazard models adjusted for body mass
index, smoking, alcohol consumption, cardiorespiratory fitness and socioeconomic status.
Results: Men with high muscle strength in adolescence had a decreased risk of later CVD events (HR 0.88, 95%
confidence interval 0.77 to 0.99), whereas we observed no increased risk in men with low muscle strength
(0.99, 0.86 to 1.13). However, low muscle strength was associated with increased risk of CVD mortality during
middle age (1.31, 1.02 to 1.67).
Conclusions: Muscle strength in adolescent men is inversely associated with later CVD events and CVD
mortality in middle age, independently of cardiorespiratory fitness and other important confounders. Thus, the
role of muscle fitness in the prevention and pathogenesis of CVD warrants increased attention.
Keywords: Cardiovascular disease, Coronary heart disease, Stroke, Muscle strength, Prevention, EpidemiologyBackground
Ischemic heart disease and stroke are major contributors to
the global burden of disease [1]. Pleasingly, the last decades
we have experienced major advances in both pharmaco-
logical and invasive treatments, which have greatly improved
the prognosis for patients after a major cardiovascular dis-
ease (CVD) event. However, primary and secondary preven-
tion are still important, both to decrease the individual
suffering as well as to decrease the societal burden. Import-
ant cornerstones of the preventive framework include a
balanced diet, no smoking and adequate levels of physical* Correspondence: simon.timpka@med.lu.se
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unless otherwise stated.activity [2]. Increasing physical activity generally increases
physical capacity, with muscular function and cardiorespira-
tory fitness (CRF) being its two main components. CRF is a
well-established predictor of future CVD morbidity [3], in-
fluencing the development of disease as well as increasing
the physiological margin if a CVD event occurs. With low
muscle fitness being an established predictor of mortality
and low health in older populations [4,5], there is also in-
creasing epidemiological evidence that muscle strength is as-
sociated with all-cause mortality independently of CRF in
adults [6-8]. In addition, there are previous studies suggest-
ing an association between muscle strength and CVD risk
factors, such as arterial stiffness [9] and long term weight
gain [10]. Currently, the World Health OrganizationLtd. This is an Open Access article distributed under the terms of the Creative
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ities on at least two separate days per week [11]. Muscle
strengthening activities might potentially be a better alterna-
tive for people who are not motivated to, or due to medical
reasons cannot, participate in more focused cardiorespira-
tory exercise. However, it is currently unknown whether
muscle strength is associated with later CVD independently
of CRF [12] although a crude association has been reported
[13].
Hence, our primary aim was to investigate the associ-
ation between overall isometric muscle strength in late
adolescence [14] and later CVD events in men, inde-
pendently of CRF. As a secondary aim, we assessed the
risk of CVD mortality. We hypothesized that overall iso-
metric muscle strength in late adolescence is associated,
not necessarily linearly, with subsequent CVD events
and CVD mortality. With follow-up until late middle age
(up to 40 years of follow-up) and careful consideration of
key confounders, we have addressed important limitations
of previous studies.
Methods
For this prospective register-based cohort study, we identi-
fied 38,588 Swedish men (Table 1). Typically aged 18 years,
the men were tested and examined during conscription for
military service between September 1969 and May 1970
(Figure 1). In 2012, we collected data on the cohort regard-
ing CVD events and mortality until late middle age via
Swedish registers on in-patient care and cause of death.
The study was approved by the Regional Ethical Review
Board at Lund University (2011/500) and is reported ac-
cording to the STROBE (STrengthening the Reporting of
OBservational studies in Epidemiology) guidelines [15].
Until 2010, conscription was mandatory by law for all
Swedish men. In 1969/1970, only persons with serious
functional impairment, such as congenital disorders,
were exempted. Six regional test offices were used, with
each testing young men in its catchment area. During a
two-day session, the men performed a battery of phys-
ical and mental tests and were also evaluated by a med-
ical doctor and a psychologist.
A small minority of subjects have incongruous anthropo-
metric data registered. Therefore, we excluded men with
an extreme value on weight (<40 kg, >150 kg), height
(<150, >210 cm) or body mass index (BMI, <15, >60 kg/m2).
To only include men in late adolescence, we also excluded
a small minority of men whom were younger than 17 years
or older than 19 years during conscription. To control for
censoring during follow-up, we used data on emigration
and immigration.
Muscle strength measurement
As a measure of general muscle strength, we used the
mean standardized score of three isometric muscle strengthtests; hand grip strength, elbow flexion and knee extension.
At baseline, the muscle strength was measured as pre-
viously described [16] (personal communication L-O
Nordesjö, 19 December 2012). However, the exact test
protocol was not available due to military restrictions.
In summary, a specially constructed “muscle chair” was
used with strain gauges (KRK-2 and KRG-4) and indicator
(BKI-1) from AB Bofors modified by AB Medicinska
Apparater, Södertälje, Sweden. Hand grip strength was
measured with the hand in a vertical position, with 90°
flexion at the elbow, and the humerus being parallel
with the torso. Elbow flexion and knee extension were
measured in a sitting position with 90° flexion over the
main joint and with straps over the radial styloid process
and 5 cm above the most distal part of the fibular malleolus,
respectively. Using percentiles of the mean standardized
score (standardized score = (value − mean)/standard
deviation), we categorized the cohort into low, average
and high strength with the 25th and 75th percentiles as
cut offs (that is, the category average strength contained
50% of the sample). By using the mean of the standardized
muscle strength scores, the relative strength of each muscle
group is equally contributing to the composite muscle
strength measure.
Covariates
Weight was measured to the nearest kilogram. Height
was measured to the nearest centimeter. We calculated
BMI as weight/height2. Smoking at baseline was catego-
rized into three groups (non-smokers, 1 to 10 cigarettes
per day and >10 cigarettes per day). Self-reported total
intake of alcohol was measured in grams per week as
previously reported [17] and categorized into four groups
(0, 1 to 100, 101 to 250, >250).
As a measure of CRF, we used physical work capacity
(in relation to body weight) categorized as low or high.
Subjects who were not limited by disease, including a
present cardiovascular condition, performed a maximal
test (Wmax6) on a cycle ergometer (Elema-Schönander
Model AM 368 or similar) [18,19]. The test has been
reported to correlate well with VO2max in young male
students (r = 0.9) [20,21], though the exact test protocol
was not available to us due to military restrictions. In
short, each subject started on the same load (230 W) and
worked until exhaustion or the prescribed pedaling rate
(60 rotations/minute) could not be upheld. For a minority
still working at 12 minutes, further increments of 30 W
were made every 6 minutes. We excluded subjects who
did not reach 90% of age-predicted maximal heart rate
(MHR) at the end of testing, that is, <175 beats/minute
(MHR= 208 − 0.7 * 18.5) [22]. The test results were regis-
tered as stanine scores with known corresponding intervals
of physical work capacity in W. A stanine scale is based on
the normal distribution and usually used for standardized
Table 1 Descriptive statistics of total study sample and the categories of muscle strength
Categories of muscle strength
Characteristics Total sample Low Average High
n = 38,588 n = 9,647 n = 19,294 n = 9,647
Mean age at start of follow-up 19.0 19.0 19.0 19.0
Mean height in centimeters (SD) 178.0 (6.3) 176.4 (6.5) 178.0 (6.2) 179.5 (6.1)
Mean mass in kilograms (SD) 66.5 (9.3) 60.9 (7.8) 66.3 (8.0) 72.4 (9.4)
Mean arm flexion strength in N (SD) 370 (79) 292 (39) 364 (48) 460 (69)
Mean knee extension strength in N (SD) 533 (103) 431 (67) 532 (69) 638 (85)
Mean hand grip strength in N (SD) 608 (98) 508 (63) 605 (64) 711 (77)
Body mass index (%)
<18.5 5,323 (13.8) 3,169 (32.8) 1,971 (10.2) 183 (1.9)
18.5 to 24.9 30,697 (79.6) 6,246 (64.7) 16,340 (84.7) 8,111 (84.1)
≥25 to 29.9 2,242 (5.8) 204 (2.1) 880 (4.6) 1,158 (12.0)
≥30 326 (0.8) 28 (0.3) 103 (0.5) 195 (2.0)
Smoking (%)
Non-smoker 15,754 (40.8) 4,125 (42.8) 7,664 (39.7) 3,965 (41.1)
1 to 10 daily cigarettes 12,646 (32.8) 3,128 (32.4) 6,438 (33.4) 3,080 (31.9)
10+ daily cigarettes 10,188 (26.4) 2,394 (24.8) 5,192 (26.9) 2,602 (27.0)
Alcohol as grams/week (%)* n = 37,620 n = 9,401 n = 18,799 n = 9,420
0 2,331 (6.2) 738 (7.9) 1,058 (5.6) 535 (5.7)
1 to 100 22,923 (60.9) 5,643 (60.0) 11,473 (61.0) 5,807 (61.6)
101 to 250 9,529 (25.3) 2,354 (25.0) 4,800 (25.5) 2,375 (25.2)
251+ 2,837 (7.5) 666 (7.1) 1,468 (7.8) 703 (7.5)
Cardiorespiratory fitness (%)* n = 30,941 n = 7,174 n = 15,694 n = 8,073
Low 15,509 (50.1) 3,403 (47.4) 7,910 (50.4) 4,196 (52.0)
High 15,432 (49.9) 3,771 (52.6) 7,784 (49.6) 3,877 (48.0)
Attained education 1990 (%)* n = 35,332 n = 8,815 n = 17,678 n = 8,839
9 years or less 12,534 (35.5) 2,887 (32.8) 6,057 (34.3) 3,590 (40.6)
Secondary 14,188 (40.2) 3,432 (38.9) 7,270 (41.1) 3,486 (39.4)
Higher 8,610 (24.4) 2,496 (28.3) 4,351 (24.6) 1,763 (19.9)
Parental socioeconomic status (%)* n = 38,581 n = 9,645 n = 19,290 n = 9,646
Blue collar 19,469 (50.5) 4,674 (48.5) 9,729 (50.4) 5,066 (52.5)
Lower white collar 10,986 (28.5) 2,696 (28.0) 5,492 (28.5) 2,798 (29.0)
Upper white collar 6,214 (16.1) 1,822 (18.9) 3,110 (16.1) 1,282 (13.3)
Other 1,912 (5.0) 453 (4.7) 959 (5.0) 500 (5.2)
SD = Standard deviation.
*The numbers represent the subjects with covariate information available.
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step each delimit 4% of the population whereas step five
constitutes 20% [23]. To allow estimation of physical work
capacity in relation to body weight as a proxy for CRF,
we estimated the exact result for each conscript using
the mean of the upper and lower limit of each stanine
score interval. Exceptions were subjects with the highest
stanine score, which we categorized as having high fitness,
independent of their body weight. Otherwise, those withthe highest score weighing the most would be systematic-
ally categorized as having low CRF.
We collected data on adult and childhood socioeconomic
status from Statistics Sweden. As a proxy for the conditions
during childhood, we used information on parental occupa-
tion and education in 1960. For a minority of subjects with
missing values, the self-reported parental socioeconomic
status at conscription was used. For categorization into
four groups, we used a white/blue collar approach. For
Figure 1 The identification of the study sample and the loss
during follow-up.
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education in 1990.
Statistical analyses
All statistical analyses were made in SAS 9.3 (SAS Institute,
Cary, NC, USA). We used Cox proportional hazard models
to calculate hazard ratios (HR) for outcomes and control
potential confounders. In model I, we adjusted for BMI
and smoking. In model II, we further adjusted for alcohol,
CRF and socioeconomic status. For the middle age ana-
lyses, all men in the cohort living in Sweden on 1 January
1991, were included in model I (37,542 men). For model II
(main model), the corresponding number was 27,766 men
(74.0%). For the mortality analysis starting in 1970, 30,186
men (78.2%) had complete information in model II.
Our primary endpoint was time to CVD event in middle
age. Due to the start of data registration on hospitalization
and attained education, the actual follow-up regarding
ischemic CVD started when the men were typically
aged 39 and continued for 20 years through middle
age. In other words, for all men alive 1 January 1991, we
collected data on hospitalizations with a CVD diagnosis
until 31 December 2010 from the nation-wide Swedish
in-patient register [24]. With few exceptions, all diagnosesfrom in-patient care in Sweden are reported to the
National Board of Health and Welfare. We defined CVD
events as coronary heart disease or stroke morbidity
(including hemorrhagic stroke but excluding transient
ischemic attack) according to diagnoses based on the
International Classification of Disease (ICD) version 9
(410 to 414, 430 to 434, 436 to 438, 342, 344) and 10
(I20 to I25, I60 to I66).
Starting 1 June 1970, we followed up on all deaths until
2 August 2012. However, the cause of death registered ac-
cording to the ICD (versions 8, 9 or 10) was not available
for deaths in 2012. Thus, the analyses of all-cause and spe-
cific mortality differed by seven months in time to follow-
up. For the period 1970 to 2011, we separately identified
deaths due to CVD (ICD-8, ICD-9: 390 to 459 ICD-10:
I00 to I99). We also separately investigated CVD and all-
cause mortality in middle age (1991 to 2011), the period
for which morbidity data was available.
Sensitivity analyses
To investigate if the measure of socioeconomic status in-
fluenced the results, we also investigated socioeconomic
status as the socioeconomic index (SEI) 1990. Further-
more, we investigated if year of birth, marital status,
height, exclusion due to heart rate <175 at the end of
CRF testing, the conscription office or blood pressure
(potential mediator) had any influence on HR estimates.
Using the first quintile of mean muscle strength as ref-
erence, we also tested trend across groups of muscle
strength. In separate analyses, we also excluded subjects
with CVD (ICD 8: 390 to 459) or psychiatric disease
(ICD 8: 290 to 315) at baseline.
Results
Lowmuscle strength was associated with low BMI (Table 1).
During 710,019 person-years of follow-up in middle age
(1991 to 2010), 1,944 men (2.7 per 1,000 person-years) were
hospitalized with CVD events. Men with high muscle
strength had a statistically significant decreased HR for
CVD events in the fully adjusted (main) model (Table 2).
During 1,569,422 person-years of total follow-up, 3,390
men (2.2 per 1,000 person-years) died with 2,610 (77.0%)
deaths occurring in middle age (1991 to 2012). A total of
167 men died in 2012 and had yet to be assigned a cause
of death at the time of data collection due to a lag in
the registration. Of the 3,223 deaths with a registered cause
of death, 687 (21.3%) were due to CVD, of which 629
(91.6%) occurred in middle age. Men with low muscle
strength had a statistically significant increased HR of
middle age CVD mortality after adjusting for BMI,
smoking, alcohol, CRF and attained education. For total
mortality, the HRs were moderately increased for both
CVD and all-cause but appeared significant in the fully
adjusted model only for the latter.
Table 2 Hazard ratio of CVD events and mortality by muscle strength with average strength as reference
Low strength (HR, 95% CI) High strength (HR, 95% CI)
Outcome Model I* Model II† Model I* Model II†
Middle age‡ morbidity
CVD events§ 0.99 (0.88 to 1.10) 0.99 (0.86 to 1.13) 0.91 (0.81 to 1.02) 0.88 (0.77 to 0.99)
Middle age mortality
CVD 1.23 (1.01 to 1.51) 1.31 (1.02 to 1.67) 1.11 (0.92 to 1.34) 0.98 (0.78 to 1.24)
All-cause 1.17 (1.06 to 1.29) 1.18 (1.04 to 1.33) 1.03 (0.94 to 1.14) 0.98 (0.87 to 1.10)
Total|| mortality
CVD 1.28 (1.06 to 1.55) 1.21 (0.96 to 1.51)¶ 1.08 (0.90 to 1.30) 1.03 (0.84 to 1.28)¶
All-cause 1.16 (1.07 to 1.27) 1.14 (1.03 to 1.26)¶ 1.03 (0.95 to 1.12) 1.04 (0.95 to 1.15)¶
CI, Confidence interval; CVD, Cardiovascular disease; HR, Hazard ratio.
Significant results are in bold (α = 0.05).
* = Adjusted for body mass index, smoking.
† =Main model. Adjusted for body mass index, smoking, alcohol, cardiorespiratory fitness, education (n = 27,766, that is, 74.0% of subjects in model I).
‡ = typically from age 39 years (1991 to 2010).
§ = coronary heart disease or stroke diagnosis (excluding transient ischemic attack) from in-patient care.
|| = typically from age 19 years (1970 to 2011/2012).
¶ =Model includes parental socioeconomic status instead of the subject’s education as follow-up starts in adolescence (n = 30,186, that is, 78.2% of subjects in model I).
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Year of birth and conscription office did not alter the
pattern of HR estimates. In general, being unmarried
was associated with an increased risk of the outcomes,
although we observed no major changes in the HR esti-
mates of muscle strength. High diastolic blood pressure
was typically associated with having a cardiovascular out-
come but had only minor effects on risk estimates. Adjust-
ing for SEI instead of education or including subjects
independently of the heart rate level at the end of CRF
testing did not affect the overall pattern of association.
Adding height to the fully adjusted models, the observa-
tions regarding all-cause and CVD mortality for the low
strength group remained essentially unchanged, whereas
the association with CVD events in the high strength
group were slightly attenuated (HR 0.92, 0.80 to 1.04).
We observed no trend across muscle strength groups
for any of the outcomes. When we excluded men with
a CVD (n = 1,271) or a psychiatric diagnosis (n = 4,324)
at baseline, we observed only minor changes of HRs
and the overall patterns remained.
Discussion
Our most important observation is that high muscle
strength in young men was associated with lower risk
of future CVD events, independently of well-known
risk factors such as CRF, smoking and BMI. As con-
firmed by a recent review [12], this is a novel finding.
In addition, we also report an increased risk of middle
age CVD mortality in men with low muscle strength,
independently of common risk factors.
Muscle strength as a risk factor for cardiovascular disease
With observations that suggest an inverse association
between muscle strength in young men and later CVD,the pathways of potential causality remain as a central
question. Does high muscle strength add CVD protection
apart from CRF or is it merely a proxy for a more favorable
future CVD risk profile? Notably, there are previous studies
supporting a biological link between muscle strength and
later CVD, such as obesity protection [6] through increased
resting energy expenditure [25] and lower arterial stiffness
in young men with high muscle strength [9]. Early devel-
opmental aspects might also play a role as birth size is
associated with both low adult muscle strength [26] as
well as ischemic heart disease [27]. Whereas we observed
a decreased risk of CVD events in men with high muscle
strength, the group had no decreased risk of CVD mortal-
ity. In contrast, having low muscle strength was associated
with increased risk of CVD mortality but not for CVD
events. Potentially, this could be explained by muscle
strength having different thresholds of protective effect
depending on the severity of the outcome measurement.
In the context of this study, there is scarce support in the
literature that any of the muscle strength tests would be
particularly associated with CRF and CVD. Thus, we have
not separately investigated each muscle strength test and
its association with the outcomes to reduce the number of
primary analyses and avoid a data mining approach. We
chose to focus the main analyses on detecting non-linear
associations as we found it more feasible to use the aver-
age muscle strength group as reference from a public
health perspective. Furthermore, the known variability in
muscle adaption following training would support a non-
linear association [28].
Low muscle strength in adolescent men has previously
been linked to an increased risk of later suicide mortality
[29]. It is plausible that subjects with psychiatric disease
or CVD at baseline perform less well on physical capacity
test in general, possibly introducing bias. However, when
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baseline, the risk estimates were only marginally altered.
When we adjusted for conscription office, a few offices
appeared statistically significant without altering the risk
estimates substantially.
Strengths and limitations
The study includes a large population-based sample,
includes prospectively ascertained exposure information
and baseline data on known confounders, has a long
follow-up of four decades, and small loss during follow-up
using comprehensive registers. However, there are also
limitations that should be considered when interpreting
the results. First of all, we do not know how the motiv-
ation for military service may have biased our observa-
tions. However, as few men were fully discharged, most
hypothetical underachievers would still have to enlist, pos-
sibly raising motivation for testing. Although morbidity
data for CVD events are missing in young adulthood, the
incidence of coronary heart disease and ischemic stroke is
low prior to middle age [30,31]. Thus, the large majority
of cases should still have been identified with the present
study design. Also, if our hypothesis is correct, early cases
not registered would at most dilute our results. It should
also be noted that all conscripts included in the study
did not perform a maximum work capacity test. As
non-performers typically have lower muscle strength
than performers, this should also at most dilute our re-
sults. Furthermore, CRF was not directly measured but
approximated from a physical work capacity test on a
bicycle. Compared to the treadmill testing used in
other studies in the area [6,8], the CRF variable might
be slightly inferior. However, CRF had a statistically
significant effect on the HR estimate of total CVD
mortality (low vs. high 1.33, 1.10 to 1.60). Noticeably,
the study design also allows us to adjust the risk esti-
mates for the mediating effects of attained education.
Previous studies have reported that changes of behav-
ior or physical fitness during adulthood affect the mor-
tality risk [32,33], data not available for the cohort.
However, when we adjust for the attained education of
subjects in their late 30s, we take some of the environmen-
tal differences in early adulthood into account. Although
widely used in both primary and secondary screening of
CVD, we do not have any data on biochemical markers of
CVD risk, such as cholesterol levels. However, we first and
foremost regard the metabolic profile of the individual as
an intermediate variable between fitness and later CVD and
not as a confounder. We have not been able to study
the effects of physical activity level on our observations
as these data were not available for the cohort. Thus,
physical activity level might mediate unmeasured con-
founder effects. From a statistical viewpoint, it is im-
portant to note that Cox proportional hazard modelsmight produce biased results when studying other out-
comes than all-cause mortality due to competing risks
(that is, death) [34]. However, we did not observe any
major differences between subgroup curves of cumula-
tive incidence compared to the corresponding curves
adjusted for competing risks.Generalization and future perspectives
In brief, as long as the limitations of the study are ac-
knowledged, we find our observations generalizable to a
male population of European ancestry. The study does
not include women as only men were subjected to con-
scription testing. Furthermore, as the muscle mass and
isometric muscle strength greatly differ among young
males and females, our study does not give sufficient
evidence to suggest a similar association in women as
in men. Although the source population was ethnically
homogenous and predominantly white, muscle strength has
been shown to be an important predictor of mortality also
in other ethnicities, such as men of Japanese ancestry [35].
We consider muscle fiber type distribution (type I or
type II) to be an area of interest for future research.
Muscle fiber type distribution has a major congenital
component [36], is affected by physical activity [37], and is
associated with isometric muscle strength [38] as well as
obesity and type 2 diabetes [39,40]. With promising tech-
niques that measure muscle fiber type non-invasively [41],
large cohort studies on how muscle fiber type distribution
is associated with CVD are possible. It is also important to
better understand how fitness interventions alter the CVD
risk for individuals with different levels of baseline fitness.Conclusions
This study provides novel evidence that overall isometric
muscle strength in young men is inversely associated
with later risk of CVD events as well as CVD mortality
in middle age, independently of CRF. We suggest that the
role of muscular function in the pathogenesis of CVD, and
the histological and biochemical links that hypothetically
might explain our observations, warrant increased attention
and further investigation.
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